Multidisciplinary Team Support for Patients With Head and Neck Cancer Receiving Radiotherapy
JAMA Network Open · 15.12.2025 · 8 (12) · e2547590
DOI: 10.1001/jamanetworkopen.2025.47590 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JAMA Network Open, online erschienen am 15.12.2025. Verfasst von Yiyan Pei und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Patient Care Team. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance Guidelines recommend nutritional, psychological, and rehabilitation support for patients with head and neck cancer during radiotherapy, but many patients, particularly in China, lack efficient access to such services.
Objective
To assess the effectiveness of Supportive Holistic Interventions by Nurses and Experts via Multidisciplinary Team (SHINE-MDT), a framework to coordinate nutritional, psychological, and rehabilitation support, at reducing radiotherapy interruptions, improving nutritional status, alleviating psychological burdens, and enhancing the quality of life (QOL) among patients with head and neck cancer undergoing radiotherapy. Design, Setting, and Participants A randomized clinical trial (RCT) of SHINE-MDT vs usual care (UC) was conducted at West China Hospital from April 27 to December 1, 2023. Adult patients aged 18 years or older with head and neck cancer undergoing radiotherapy were enrolled.
Interventions
Eligible patients were randomly allocated (1:1) to either UC or SHINE-MDT. The SHINE-MDT group received nutritional, psychological, and rehabilitation support delivered by a team including oncology nurse specialists, radiation and medical oncologists, dietitians, psychotherapists, and rehabilitation physicians. The UC group received supportive measures aligned with standard practice. Main Outcomes and Measures The primary outcome was the radiotherapy interruption rate in the intent-to-treat population. Secondary outcomes included patient-reported QOL assessed using the European Organisation for Research and Treatment of Cancer QOL Questionnaire–Core 30 (QLQ-C30). Nutritional status was evaluated using Nutrition Risk Screening 2002 (NRS-2002) and the Patient-Generated Subjective Global Assessment (PG-SGA) and psychological status using a distress thermometer (DT), the Patient Health Questionnaire–9 (PHQ-9), and the Hospital Anxiety and Depression Scale (HADS). Assessments from baseline through 6 months posttreatment were analyzed using mixed-effects models for intergroup comparisons.
Results
A total of 233 patients were enrolled (mean [SD] age, 51.7 [13.9] years; mean [SD] body mass index [calculated as weight in kilograms divided by height in meters squared], 23.8 [3.3]; 158 males [67.8%]). The radiotherapy interruption rate in the SHINE-MDT group was 13.9 (95% CI, 4.2-23.6) percentage points lower than that in the UC group (11.1% [95% CI, 6.0%-18.2%] vs 25.0% [95% CI, 17.2%-34.2%]; P = .003). The SHINE-MDT group had superior outcomes compared with the UC group at the end of radiotherapy, with better global health status (mean QLQ-C30 score, 68.59 [95% CI, 65.83-71.35] vs 64.06 [95% CI, 61.48-66.64]; P = .009), improved mean psychological status scores (DT: 3.02 [95% CI, 2.68-3.35] vs 4.30 [95% CI, 4.00-4.59]; HADS-Anxiety: 4.96 [95% CI, 4.27-5.66] vs 7.27 [95% CI, 6.44-8.12]; HADS-Depression: 4.48 [95% CI, 4.00-4.98] vs 6.06 [95% CI, 5.42-6.70]; PHQ-9: 2.22 [95% CI, 1.73-2.72] vs 3.49 [95% CI, 2.94-4.03]; all P < .001), and better nutritional indicators reflected by lower mean NRS-2002 (2.19 [95% CI, 2.07-2.31] vs 2.80 [95% CI, 2.62-2.96]) and PG-SGA (6.89 [95% CI, 6.17-7.61] vs 10.19 [95% CI, 9.27-11.11]) (both P < .001) scores. Conclusions and Relevance In this RCT, the SHINE-MDT intervention reduced radiotherapy interruptions, improved nutritional status, alleviated psychological burdens, and elevated QOL, indicating this framework may improve the holistic well-being of patients with head and neck cancer receiving radiotherapy. Trial Registration ClinicalTrials.gov Identifier: NCT05828004
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- Sichuan Provincial Key Laboratory of Nuclear Physics and Medical Research, Sichuan University, Chengdu, Sichuan, China.
- Department of Oncology, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
- Department of Nursing, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu, Sichuan, China.
- Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- Department of Head and Neck Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Zitieren
APA
Pei, Y., Wang, J., Li, J., Chen, Y., He, J., Wei, Z., Liu, Z., Su, Y., Dai, T., Yin, L., Deng, Y., Zhou, J., Tian, H., Li, Y., Chen, X., Zhang, S., Chen, Y., Yan, Q., Li, R., …, & Peng, X. (2025). Multidisciplinary Team Support for Patients With Head and Neck Cancer Receiving Radiotherapy. JAMA Network Open, 8(12), e2547590. https://doi.org/10.1001/jamanetworkopen.2025.47590
Vancouver
Pei Y, Wang J, Li J, Chen Y, He J, Wei Z, et al. Multidisciplinary Team Support for Patients With Head and Neck Cancer Receiving Radiotherapy. JAMA Network Open. 2025;8(12):e2547590. doi:10.1001/jamanetworkopen.2025.47590
BibTeX
@article{Pei2025,
author = {Pei, Yiyan and Wang, Jingjing and Li, Juejin and Chen, Ye and He, Jinlan and Wei, Zhigong and Liu, Zheran and Su, Yonglin and Dai, Tingting and Yin, Li and Deng, Yaotiao and Zhou, Jitao and Tian, Hangrui and Li, Yunhuan and Chen, Xiaoli and Zhang, Shu and Chen, Yang and Yan, Qianwen and Li, Ruidan and Jiang, Zheng and Hu, Xiaolin and Peng, Xingchen},
title = {Multidisciplinary Team Support for Patients With Head and Neck Cancer Receiving Radiotherapy},
journal = {JAMA Network Open},
year = {2025},
volume = {8},
number = {12},
pages = {e2547590},
doi = {10.1001/jamanetworkopen.2025.47590}
}
EUVIMED